Author(s)
Bianca A Trombetta
Published 2 Projects
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Savannah E. Kandigian
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Robert R. Kitchen
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Korneel Grauwet
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Pia Kivisäkk Webb
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Glenn A. Miller
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Charles G. Jennings
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Sejal Jain
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Samara Miller
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Yikai Kuo
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Thadryan Sweeney
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Tal Gilboa
Published 6 Projects
COVID-19 Coronavirus Immunology SARS-CoV-2 Infectious Diseases
Christopher E. Ramirez
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Melissa Bedard
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Catherine Fink
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Jina Ko
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Esmarline J. De LeĂłn Peralta
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Gerald Watts
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Emma Gomez-Rivas
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Vannessa Davis
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Rocky Barilla
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Jianing Wang
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Pierre Cunin
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Samuel Bates
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Chevaun Morrison-Smith
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Benjamin Nicholson
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Edmond Wong
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Leena El-Mufti
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Michael Kann
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Anna Bolling
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Brooke Fortin
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Hayden Ventresca
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Wen Zhou
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Santiago Pardo
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Megan Kwock
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Aditi Hazra
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Leo Cheng
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Q. Rushdy Ahmad
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
James A. Toombs
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Rebecca Larson
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Haley Pleskow
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Nell Meosky Luo
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Christina Samaha
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Unnati M. Pandya
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Pushpamali De Silva
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Sally Zhou
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Zakary Ganhadeiro
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Sara Yohannes
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Rakiesha Gay
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Jacqueline Slavik
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Shibani S Mukerji
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Becky C Carlyle
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Lauren L. Ritterhouse
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Sara Suliman
Published 1 Project
COVID-19 Coronavirus Infectious Diseases Antibodies Lateral Flow Assays.
Content
Video Abstract (AI generated) (02:01) Paper PreprintBackgroundCOVID-19 has resulted in significant morbidity and mortality worldwide. Lateral flow assays can detect anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) antibodies to monitor transmission. However, standardized evaluation of their accuracy and tools to aid in interpreting results are needed. MethodsWe evaluated 20 IgG and IgM assays selected from available tests in April 2020. We evaluated the assays performance using 56 pre-pandemic negative and 56 SARS-CoV-2-positive plasma samples, collected 10-40 days after symptom onset, confirmed by a molecular test and analyzed by an ultra-sensitive immunoassay. Finally, we developed a user-friendly web app to extrapolate the positive predictive values based on their accuracy and local prevalence. ResultsCombined IgG+IgM sensitivities ranged from 33.9% to 94.6%, while combined specificities ranged from 92.6% to 100%. The highest sensitivities were detected in Lumiquick for IgG (98.2%), BioHit for both IgM (96.4%), and combined IgG+IgM sensitivity (94.6%). Furthermore, 11 LFAs and 8 LFAs showed perfect specificity for IgG and IgM, respectively, with 15 LFAs showing perfect combined IgG+IgM specificity. Lumiquick had the lowest estimated limit-of-detection (LOD) (0.1 g/mL), followed by a similar LOD of 1.5 g/mL for CareHealth, Cellex, KHB, and Vivachek. ConclusionWe provide a public resource of the accuracy of select lateral flow assays with potential for home testing. The cost-effectiveness, scalable manufacturing process, and suitability for self-testing makes LFAs an attractive option for monitoring disease prevalence and assessing vaccine responsiveness. Our web tool provides an easy-to-use interface to demonstrate the impact of prevalence and test accuracy on the positive predictive values.
More Projects
Loren Frank
13 views • 2 years ago
Global Immunotalks
390 views • 3 years ago
Laurel Yohe
2 views • 2 years ago
Global Immunotalks
130 views • 3 years ago
Jignesh H. Parmar
0 views • 2 years ago
Winston A. Haynes
0 views • 2 years ago
Noam Mazor
0 views • 2 years ago
Global Immunotalks
182 views • 3 years ago
Cem Yuksel
345 views • 3 years ago
Oscar Gonzalez-Recio
3 views • 2 years ago
Please pick a style:
Tal Gilboa. (2021, Oct 25).Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2[Video]. Scitok. https://scitok.com/project/p/579526aa
A Trombetta Bianca. "Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2" Scitok, uploaded by Gilboa Tal, 25 Oct, 2021, https://scitok.com/project/p579526aa
Tal Gilboa. "Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2" Scitok. (Oct 25, 2021). https://scitok.com/project/p/579526aa
Tal Gilboa (Oct 25, 2021). Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2 Scitok. https://scitok.com/project/p/579526aa
Tal Gilboa. Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2[video]. 2021 Oct 25. https://scitok.com/project/p/579526aa
@online{al2006link, title={ Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2 }, author={ Gilboa, Tal }, organization={Scitok}, month={ Oct }, day={ 25 }, year={ 2021 }, url = {https://scitok.com/project/p/579526aa}, }